Investor Info

FSI is a holding company traded on the NYSE-American Exchange. It operates through Flexible Solutions Ltd of Canada, NanoChem Solutions Inc. of Nevada and Illinois and ENP LLC of Illinois.

FSI is a holding company traded on the NYSE-American Exchange. It operates through Flexible Solutions Ltd of Canada, NanoChem Solutions Inc. of Nevada and Illinois and ENP LLC of Illinois.

Daniel B. O’Brien is the CEO and a Director of the Company. The Company has employed him since its inception. His responsibilities include coordinating strategy, planning, and product development. He has been involved in the swimming pool industry since 1991 at which time he founded a private company called Flexible Solutions Ltd., which was purchased by the Company, through the share exchange in August 1998. Prior to his involvement with Flexible Solutions Ltd., Mr. O’Brien was a teacher at Brentwood College where he was in charge of Outdoor Education.

This page is currently being updated.

Quarterly and Yearly SEC Reports can be found below. They are in PDF file format* and will open a new window when clicked. Please contact us if you have any difficulties viewing the reports.

Annual General Meeting reports:

In the future if you would like Annual General Meeting (AGM) information sent by email, please click here to send, with ‘AGM’ in the subject line.

*Note XBRL filings are compressed zipped files and download onto your machine.

2024XBRL Filing
Q1 2024Q1 2024 XBRL
Q2 2024Q2 2024 XBRL
Q3 2024Q3 2024 XBRL
XBRL Filing
Q1 2023FSI Q1 2023 iXBRL
Q2 2023FSI Q2 XBRL
Q3 2023FSI Q3 XBRL
FSI 10K 2023FSI20231231.XBRL

2022

Q12022

Q22022

Q32022

10K2022

2021

Q12021

Q22021

Q32021

10K2021

XBRL Filing

fsi-20210331

fsi-20210630

fsi-20210930

fsi-20211231

2020

Q12020

Q22020

Q32020

10K2020

XBRL Filing

fsi-20200331

fsi-20200630

fsi-20200930

fsi-20201231

2019

Q12019

Q22019

Q32019

10K2019

XBRL Filings

fsi-20190331

fsi-20190630

fsi-20190930

fsi-20191231

2018

Q12018

Q22018

Q32018

10Ka2018

XBRL Filings

fsi-20180331

fsi-20180630

fsi-20180930

fsi-20181231

2017

Q12017

Q22017

Q32017

10K2017

XBRL Filings

fsi-20170331

fsi-20170630

fsi-20170930

fsi-20161231

2016

Q12016

Q22016

Q32016

10K2016

XBRL Filings

fsi-20160331

fsi-20160630

fsi-20160930

fsi-20161231

2015

Q12015

Q22015

Q32015

10K2015

XBRL Filings

fsi-20150331

fsi-20150630

fsi-20150930

fsi-20151231

2014

Q12014

Q22014

Q32014

10k2014

XBRL Filings

fsi-20140331

fsi-20140630

fsi-20140930

2013

Q12013

Q22013

Q32013

10K2013

XBRL Filings

fsi-20130331

fsi-20130630

fsi-20130930

fsi-20131231

   2012

Q12012

Q22012

Q32012

YearEnd2012

    XBRL Filings

fsi-20120331

fsi-20120630

fsi-20120930

20121231pre

    2011

Q12011

Q22011

Q32011

YearEnd2011

XBRL Filings

fsi-20110630

fsi-20110930

fsi 20111231

    2010

Q12010

Q22010

Q32010

YearEnd2010  

2009

Q12009

Q22009

Q32009

YearEnd 2009

2008

Q12008

Q22008

Q32008

YearEnd 2008

2007

Q12007

Q22007

Q32007

Year End 2007

2006

Q12006

Q22006

Q32006

10KSB 2006

2005

Q12005

Q22005                       

Q32005

Annual Report

2004             

Q1 2004

Q2 2004

Q3 2004

Annual Report

 

2003

Q1 2003

Q2 2003

Q3 2003 

Annual Report

Q1 2003

MDA

2002

Q1 2002

Q2 2002

Q3 2002

Year End 2002 

The President’s Report    
MDA 2002  

2001
Q1 2001

Q2 2001

Q3 2001

Year End 2001

2000
   Year End 2000
   Q3 2000
   Q2 2000

14 Nov. 2024 – FSI Announces Third Quarter 2024 Financial Results

17 Oct. 2024 – FSI Announces Third Quarter 2024 Revenue

14 August 2024- FSI Announces Second Quarter 2024 Financial Results

12 August 2024 – FSI Announces Sale of Florida LLC Units

5 June 2024 – FSI Announces CAPEX Expenditure to acquire a vial filling line for injectable drugs such as GLP1 for weight loss

15 May 2024- FSI Announces First Quarter 2024 Financial Revenue

23 April 2024- FSI Announces First Quarter 2024 Revenue and Distribution

29 March 2024 — FSI Announces Full Year 2023 Financial Revenue 

22 Jan. 2024–FSI Announces Fourth Quarter and Full Year 2024 Revenue

14 Nov. 2023–FSI Announces Third Quarter 2023 Financial Results

16 Oct. 23–FSI Announces Third Quarter 2023 Revenue

14 August 23 –FSI Announces Second Quarter 2023 Financial Results

17 July 23 — FSI Announces Second Quarter 2023 Revenue

6 July23–FSI Invests in LLC That Owns Industrial Building in Mendota, Il

15 May 23– FSI Announces First Quarter 2023 Financial Results

14 Apr.23 — FSI Announces Five Cent Special Dividend to be paid May 16 to Shareholders of Records April 28

13 Apr.23–FSI Announces First Quarter 2023 Revenue

12 Jan.23 — FSI Announces Record Q4 and Full Year 2022 Revenue

14 Nov. 22 — FSI announces record Q3 revenue, record year to date revenue and record year to date earnings of $0.35 cents per share

19 Oct. 22 — FSI Announces Third Quarter 2022 Revenue

30 September 2022 – FSI Announces Termination of Merger with Lygos Inc

15 August 2022 – FSI Announces Second Quarter 2022 Financial Results

18 July 2022 – FSI Announces Second Quarter, 2022 Revenue

15 June 2022 – FSI Announces Food Grade Compliance at the NanoChem Factory in Peru, Illinois

21 April 2022 – FSI Announces First Quarter, 2022 Revenue

18 APRIL 2022 – Lygos and Flexible Solutions International Announce Definitive Merger Agreement to Form Leading Sustainable Specialty Ingredient Company

March 29, 2022 – FSI Announces Full Year, 2021 Financial Results

Information on insider trading can be found at www.sec.gov.

William Gregozeski, CFA – Independant Analyst

Director of Research

Office:   +1 414 435 1110

Mobile:  +1 414 248 4935

wgregozeski@greenridgeglobal.com

Greenridge Global, LLC
10 S. Riverside Plaza, Suite 875

Chicago, IL 60606 USA

 

June 2010 http://smallcaps.us/blog/?p=747.

Small Caps US audio Nov. 2008: http://www.smallcaps.us/Interviews/FSI/default.htm

The Puglusi Report (December 2003)

You can find all of our News Releases here.

Shareholders can access all proxy materials on this webpage.  Please click on each document’s link in order to view or print the document. 

To vote on the matters described in the Proxy Statement:

  • click on the Proxy card;
  • print the Proxy card;
  • with a pen, mark your selections on the Proxy card; and
  • sign and date the Proxy card and mail the Proxy card to the address indicated on the Proxy card.

Materials:

The Annual Shareholders’ Meeting will be held at  Unit 15 – 6782 Veyaness Rd., Saanichton, BC Canada V8M 2C2 on December 6, 2023, at 4:00 p.m. Pacific Time, for the following purposes: (1) to elect the directors who shall constitute the Company’s Board of Directors for the ensuing year; (2) to approve the adoption of the Company’s Stock Incentive Plan; (3) to approve on an advisory basis, the compensation of the Company’s executive officers; (4) to approve, on a non-binding advisory basis, the frequency of the advisory vote regarding the compensation of the Company’s executive officers; (5) to ratify the appointment of Smythe, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 and to transact such other business as may properly come before the meeting. October 24, 2023 is the record date for the determination of shareholders entitled to notice of and to vote at such meeting. Shareholders are entitled to one vote for each share held. As of October 24, 2023 there were 12,435,532 outstanding shares of the Company’s common stock.

Please click here to view in PDF format. Will open in new window.

Flexible Solutions International, Inc. (the “Company”) is committed to the highest ethical standards and to conducting its business with the utmost integrity. An unwavering adherence to high ethical standards provides a strong foundation on which the Company’s business and reputation can thrive, and is integral to creating and sustaining a successful, high-caliber company. The Company’s reputation depends on the conduct of its directors and employees. Every employee and director must play a part in maintaining the Company’s reputation for the highest ethical standards.

Ethics

The Company and each of its employees and directors must conduct their affairs with uncompromising honesty and integrity. Each Company employee and director is required to adhere to the highest ethical standards.

Employees and directors are expected to be honest and ethical in dealing with each other, with clients, customers, vendors and all other third parties.

All employees and directors must also respect the rights of fellow employees and third parties. Employee and director actions must be free from discrimination, libel, slander or harassment. Each person must be accorded equal opportunity, regardless of race, religion, sex, sexual orientation, age, national origin, disability or any other protected characteristic.

Misconduct cannot be excused because it was directed or requested by another. All employees and directors are expected to alert management whenever an illegal, dishonest or unethical act is discovered or suspected; employees and directors will never be penalized for reporting discoveries or suspicions.

The following statements concern frequently raised ethical concerns. A violation of the standards contained in this Code of Business Conduct and Ethics will result in corrective action, including possible dismissal.

Conflicts of Interest

The Company expects its employees and directors to perform their duties using their best impartial judgment in all matters affecting the Company. All employees and directors must avoid any personal activity, investment or association that would interfere – or that could appear to interfere – with good and objective judgment concerning the Company’s best interests. Employees and directors may not exploit their position or relationship with the Company for personal gain, and should avoid even the appearance of such a conflict. For example, there is a likely conflict of interest if an employee or director:

  •  causes the Company to engage in business transactions with relatives or friends;
  • uses nonpublic Company, client, customer or vendor information for the employee’s personal gain, or for the benefit of relatives or friends (including securities transactions based on such information);
  • has more than a modest financial interest in the Company’s clients, customers, vendors or competitors;
  • receives a loan, or guarantee of obligations, from the Company or a third party as a result of his or her position at the Company;
  • competes, or prepares to compete, with the Company while still employed by the Company; or takes for herself or himself personally opportunities that are discovered through the use of Company property, information or position.

There are other situations in which a conflict of interest may arise. If you know of a conflict of interest or have concerns about any situation affecting the Company, follow the steps outlined under “Reporting Ethical Violations,” below.

Gifts, Bribes and Kickbacks

Other than for modest gifts given or received in the normal course of business (including meals, travel or entertainment), neither employees, directors nor their relatives may give gifts to, or receive gifts from, the Company’s clients, customers or vendors. Other gifts may be given or accepted only with the prior approval of the Chief Financial Officer or an Executive Vice President. In no event should an employee or director put himself or herself or the Company in a position that would be embarrassing if the gift were made public.

Dealing with government employees is often different than dealing with private persons. Many governmental bodies strictly prohibit the receipt of any gratuities by their employees, including meals and entertainment. Employees and directors must be aware of and strictly follow these prohibitions.

Any employee or director who pays or receives a bribe or kickback, including any item intended to improperly obtain favorable treatment, will be immediately terminated and reported, as warranted, to the appropriate authorities.

Loans

Officers and directors may not request or accept a loan or payroll advance from the Company except in the limited circumstances permitted by Section 13(k) of the Securities Exchange Act of 1934, as amended.

Improper Use or Theft of Company Property

Every employee and director must safeguard Company property from loss or theft, and may not take Company property for personal use. Theft, carelessness and waste have a direct impact on the Company’s profitability. Company property includes confidential information, (such as customer lists and internal financial reports), software, computers, office equipment, and supplies. All employees and directors must appropriately secure all Company property within their control to prevent its unauthorized use. Using Company computers or communications systems to access or distribute personal or “non-business related” information, data or graphics is strictly prohibited.

Covering Up Mistakes; Falsifying Records

Mistakes should never be covered up, but should be immediately fully disclosed and corrected. Falsification of any Company, client, customer or third party record is prohibited.

Confidential Information

Company, client, customer or vendor confidential or proprietary information property is to be used solely for the benefit of the Company and its clients, customers or venders, respectively. Employees and directors may not use or reveal such information to others, nor use such information for their personal benefit. This includes business methods, pricing and marketing data, strategy, computer code, forms, information about the Company’s current, former and prospective clients, customers and employees, and any other information that might be of use to competitors or harmful to the Company or its clients, customers or vendors if disclosed.

Employees and directors may not accept, use or disclose the confidential information of our competitors. When obtaining competitive information, employees and directors must not violate our competitors’ rights. Particular care must be taken when dealing with competitors’ current or former clients, customers and employees. Employees and directors must never ask for confidential or proprietary information, and must never ask a person to violate a non-compete or non-disclosure agreement. If you are uncertain, the Chief Financial Officer can assist you.

Defamation and Misrepresentation

Aggressive marketing should not include any misstatements, innuendo or rumors about the Company’s competition or their properties, products or financial condition. Employees and directors must not make unsupportable promises concerning the Company’s properties or products.

Use of the Company and Third Party Software

Company and third party software may be distributed and disclosed only to employees authorized to use it, and to clients in accordance with terms of a Company agreement. Company and third party software may not be copied without specific authorization and may only be used to perform assigned responsibilities. All third-party software must be properly licensed. The license agreements for such third party software may place various restrictions on the disclosure, use and copying of software.

Fair Dealing

No employee or director should take unfair advantage of anyone through manipulation, concealment, abuse of privileged information, misrepresentation of material facts, or any other unfair-dealing practice.

Fair Competition and Antitrust Laws

The Company must comply with all applicable fair competition and antitrust laws. These laws attempt to ensure that businesses compete fairly and honestly and prohibit conduct seeking to reduce or restrain competition. If you are uncertain whether a contemplated action raises unfair competition or antitrust issues, the Chief Financial Officer can assist you. In addition, there are laws governing the Company’s conduct in business with foreign companies and individuals (such as the Foreign Corrupt Practices Act). If you deal with international issues, contact the Chief Financial Officer for more information on these laws.

Securities Trading

It is generally illegal to buy or sell securities using material information not available to the public. Anyone who gives such undisclosed “inside” information to others may be as liable as those who trade securities while possessing such information. Securities laws may be violated if an employee or a director or any of an employee’s or director’s relatives or friends trade in securities of the Company or any of its clients, customers or vendors, while possessing “inside” information. If you are uncertain about a particular securities issue, the Chief Financial Officer or the Controller can assist you.

Financial Reporting; Communications with the Public

The Company has high standards for achieving its operating and financial goals. These results must be achieved with high ethical standards for accounting and financial reporting methods. Accounting and financial reporting practices must be fair and proper, in accordance with accounting principles generally accepted in the United States, and must involve management’s best judgments where necessary.

The Company does not condone practices that might lead to fraudulent financial reporting. While difficult to give an all-inclusive definition of fraudulent financial reporting, it is in general any intentional or reckless conduct, whether by act or omission, that results in materially misleading financial statements. The Company expects clear, open and frequent communication among all directors and employees on all significant financial and operating matters to help reduce the risk of problems in the accounting and financial reporting areas as well as to help achieve operating goals.

The disclosures the Company makes in reports and documents that the Company files with, or submits to, the Securities and Exchange Commission and the American Stock Exchange (or other self-regulatory exchange or market), as well as in other public communications made by the Company, must be full, fair, accurate, timely and (importantly) understandable to the public.

The Chief Executive Officer and Chief Financial Officer of the Company is responsible for authorizing the release of information to the public.

Political Contributions

In the United States, corporate political contributions for federal and some state elections are illegal. Accordingly, no direct or indirect contributions can be made in association with any federal, state or local election, without the approval of the Chief Executive Officer or Chief Financial Officer. Employees and directors may not engage in political activity utilizing Company resources or during regular business hours. However, employees and directors may engage in political activity with their personal resources on personal time.

Legal Obligations

Adherence to legal and regulatory matters must govern the business decisions and actions of every Company employee and director. All employees and directors should make every effort to ensure that they and the Company are in compliance with all governmental laws, rules and regulations applicable to their area of employment. Any legal, regulatory or governmental inquiry or action should be directed to, and handled by the Chief Financial Officer.

Waivers

This Code of Business Conduct and Ethics applies to all Company employees and its Board of Directors. There shall be no waiver of any part of this Code except by a vote of the Board of Directors or a committee designated by the Board. Prior to such a vote, the Board or Committee must ascertain whether a waiver is appropriate and ensure that any waiver is accompanied by appropriate controls designed to protect the Company.

In the event that any waiver is granted for an executive officer or director, the waiver will be posted on the Company website, thereby allowing Company’s shareholders to evaluate the merits of the particular waiver.

Reporting Ethical Violations

If you are unable to prevent suspected misconduct before it occurs or discover it after it has occurred, you should immediately report it to the Chief Executive Officer or Chief Financial Officer]. If you are still concerned after speaking with the Chief Executive Officer or Chief Financial Officer or feel uncomfortable speaking with them for any reason, you may anonymously send a letter, with relevant documents detailing the alleged ethical violation, to the Company by contacting any of the independent directors through any of the Corporation’s offices. Your letters will be forwarded to the director to be dealt with anonymously and confidentially. In any event, you have the Company’s commitment that you will be protected from retaliation.

Enforcement and Accountability

Officers, employees and directors of the Company are responsible for the enforcement of the standards contained in this Code of Business Conduct and Ethics.

Officers, directors and appropriate employees of the Company will be required on an annual basis to certify their compliance with this Code.

Any employee or director who ignores or violates any of the Company’s ethical standards as detailed in this Code of Business Conduct and Ethics, and any director, employee, manager or officer who penalizes a subordinate for trying to follow these ethical standards, will be subject to corrective action, including immediate dismissal.